| Expression pattern: |
DN |
| Associated gene: |
TEK, Ago2 |
| Associated microRNA: |
miR-556-5p |
| Biological function: |
Inhibits LUAD cell viability, migration, proliferation and tumor growth, and promotes apoptosis; acts as a tumor suppressor in LUAD. |
| Molecular mechanism: |
Hsa_circ_0070661 functions as a ceRNA by sponging miR-556-5p to release/upregulate TEK, thereby inhibiting LUAD progression. |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); apoptosis (promotes); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; Transwell Assay; Western Blot; In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
Provides a promising molecular target for LUAD clinical therapy and valued biomarkers for LUAD diagnosis. |
| Description: |
Hsa_circ_0070661 is down-regulated in LUAD tissues and cell lines and mainly localized in the cytoplasm. Its overexpression suppresses LUAD cell proliferation/viability, migration and xenograft tumor growth while promoting apoptosis. Mechanistically, it sponges miR-556-5p to relieve repression of TEK, supporting its role as a tumor-suppressive circRNA and potential therapeutic target. |
| Confidence score: |
0.7785 |